Oversea-Chinese Banking Corp (OCBC)’s Elevance Health ELV Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,532	Closed	-$572K	–	338
2025 Q2	$572K	Buy	1,532 +818	+115%	+$329K	0.02%	239
2025 Q1	$311K	Buy	714 +17	+2%	+$6.82K	0.01%	338
2024 Q4	$259K	Buy	+697	New	+$292K	0.01%	327
2024 Q1	–	Sell	-654	Closed	-$308K	–	367
2023 Q4	$308K	Sell	654 -655	-50%	-$303K	0.01%	272
2023 Q3	$570K	Buy	1,309 +324	+33%	+$147K	0.03%	242
2023 Q2	$438K	Sell	985 -2	-0.2%	-$923	0.02%	235
2023 Q1	$454K	Sell	987 -1,349	-58%	-$642K	0.02%	233
2022 Q4	$1.2M	Buy	+2,336	New	+$1.19M	0.07%	156

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s ELV Position: Q3 2025 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 1,532 shares — an estimated $572K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in ELV in Q4 2022 and held it in 8 quarters. The position peaked at $1.2M in Q4 2022. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

Oversea-Chinese Banking Corp (OCBC) reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
Oversea-Chinese Banking Corp (OCBC) sold 1,532 Elevance Health shares in Q3 2025, an estimated $572K.
Oversea-Chinese Banking Corp (OCBC) first reported a position in Elevance Health in Q4 2022 and held it in 8 quarters.
Oversea-Chinese Banking Corp (OCBC)'s Elevance Health position peaked at $1.2M in Q4 2022.
1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q3 2025, filed 28 Oct 2025.